We are live on ! Find out more
FWP

Forward Pharma A/S American Depositary Shares

Delisted

FWP was delisted on the 27th of December, 2022.

13 hedge funds and large institutions have $7.68M invested in Forward Pharma A/S American Depositary Shares in 2018 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 4 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

44% more funds holding

Funds holding: 913 (+4)

50% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 4

62% less capital invested

Capital invested by funds: $20M → $7.68M (-$12.3M)

Holders
13
Holders Change
+4
Holders Change %
+44.44%
% of All Funds
0.29%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
2
Reduced
4
Closed
1
Calls
Puts
Net Calls
Net Calls Change

FWP Hedge Fund Activity: Q4 2018 in Review

13 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in Forward Pharma A/S American Depositary Shares (FWP) for Q4 2018, worth a combined $7.68M — down 62% from $20M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new FWP positions and 1 closed out — a net gain of 5 holders — while 2 added to existing stakes and 4 trimmed.

The largest buyer was Newtyn Management, opening a new position worth an estimated $1.53M. The largest seller was Acadian Asset Management, exiting entirely with an estimated $43K sold.

  • 13 institutional investors held Forward Pharma A/S American Depositary Shares (FWP) as of Q4 2018, up from 9 in Q3 2018.
  • Funds reported $7.68M of Forward Pharma A/S American Depositary Shares stock for Q4 2018, down 62% quarter-over-quarter.
  • 6 funds opened new Forward Pharma A/S American Depositary Shares positions in Q4 2018 and 1 closed out, a net change of +5 holders.
  • The largest Forward Pharma A/S American Depositary Shares buyer in Q4 2018 was Newtyn Management, an estimated $1.53M added.
  • The largest Forward Pharma A/S American Depositary Shares seller in Q4 2018 was Acadian Asset Management, an estimated $43K sold.

Based on aggregated 13F filings for Q4 2018.